Trial Details
COMPLETEDBasic Information
| Clinical ID | c1500 |
|---|---|
| Identifier | NCT02750800 |
| Trial Title | Post-marketing Observational Study to Evaluate the Incremental Impact of AbbVie's Patient Support Program on Patient Reported Outcomes and Health Resource Utilization in Inflammatory Arthritis, Psoriasis and Inflammatory Bowel Diseases in Hungary (VALUE) |
| Trial URL | Visit Original Page |
Study Information
| Study Results | YES |
|---|---|
| Conditions | Rheumatoid Arthritis|Ankylosing Spondylitis|Psoriatic Arthritis|Psoriasis|Crohn's Disease|Ulcerative Colitis |
| Interventions | BIOLOGICAL: Adalimumab|BEHAVIORAL: AbbVie Care 2.0 |
Participant Information
| Sponsor | AbbVie |
|---|---|
| City | - |
| Country/Region | - |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | OBSERVATIONAL |
|---|---|
| Phase | - |
Time Information
| Start Date | 2016-04-07 |
|---|---|
| Primary Completion Date | 2018-04-03 |
| Completion Date | 2018-04-03 |